Prelude Capital Management’s Precigen PGEN Stock Holding History

Prelude Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-700	Closed	-$2K	–	1816
2020 Q3	$2K	Sell	700 -800	-53%	-$3.8K	﹤0.01%	1678
2020 Q2	$7K	Buy	+1,500	New	+$5.1K	﹤0.01%	1649
2019 Q1	–	Sell	-100,000	Closed	-$654K	–	2072
2018 Q4	$654K	Hold	100,000	–	–	0.04%	396
2018 Q3	$1.72M	Hold	100,000	–	–	0.1%	230
2018 Q2	$1.39M	Buy	+100,000	New	+$1.69M	0.09%	238
2017 Q2	–	Sell	-47,800	Closed	-$947K	–	1792
2017 Q1	$947K	Buy	+47,800	New	+$1.07M	0.09%	242

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Prelude Capital Management's PGEN Position: Q1 2026 in Review

Prelude Capital Management increased its Precigen (PGEN) stake by 95% in Q1 2026, buying an estimated $2.54M and bringing the position to 1,270,053 shares worth $4.92M. The position accounts for 0.38% of the portfolio, ranked #52.

Prelude Capital Management first reported a position in PGEN in Q4 2013 and has held it in 10 quarters since. 205 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

Prelude Capital Management held 1,270,053 shares of Precigen worth $4.92M as of Q1 2026.
Prelude Capital Management bought 620,079 Precigen shares in Q1 2026, an estimated $2.54M.
Precigen made up 0.38% of Prelude Capital Management's portfolio in Q1 2026, its #52 holding.
Prelude Capital Management first reported a position in Precigen in Q4 2013 and has held it in 10 quarters since.
205 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.